FDA warns Chi­nese drug­mak­er for se­ri­ous GMP record vi­o­la­tions

The FDA on Tues­day re­leased a warn­ing let­ter sent to Chi­na-based drug­mak­er Jiang­su Hen­grui Phar­ma­ceu­ti­cals, find­ing the com­pa­ny failed at mul­ti­ple lev­els to en­sure its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER